Category: Ecosystem News

$7.3 Million Advanced Industries Awards Fuel 27 Colorado Start-ups

By: Colorado BioScience Association   Date: 05/26/2020

Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program realeased a list of 27 Colorado start-ups approved for funding. A total of...

Learn More

ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions

By: Colorado BioScience Association   Date: 05/20/2020

ArcherDX, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as a compa...

Learn More

Accure Receives CE Mark Approval for First-Ever 1726nm Laser Platform to treat Acne

By: Colorado BioScience Association   Date: 05/16/2020

Groundbreaking platform combines novel laser wavelength with fully integrated tissue temperature monitoring and control systems to deliver a paradigm-shifting non-systemic solution for acne sufferers....

Learn More

Bayer and ArcherDX Announce Global Collaboration to Develop Next-Generation Sequencing (NGS)-based Companion Diagnostic (CDx) for VITRAKVI® (larotrectinib)

By: Colorado BioScience Association   Date: 05/14/2020

Collaboration will focus on development of a companion diagnostic (CDx) for Vitrakvi®, the first-in-class tyrosine kinase (TRK) inhibitor approved in the U.S. and Europe for adult pediatric patients w...

Learn More

Tolmar Pharmaceuticals Receives FDA Approval

By: Colorado BioScience Association   Date: 05/05/2020

FDA Approves FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty. Fensolvi is the only six-month, subcutaneously administered leuprolide ace...

Learn More

Global Plasma Leaders Collaborate to Accelerate Development of Potential Covid-19 Hyperimmune Therapy

By: Colorado BioScience Association   Date: 04/09/2020

Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19. Learn more in the press release.

Learn More

MBio to Seek FDA Approval for LightDeck® Platform

By: Colorado BioScience Association   Date: 04/07/2020

MBio Diagnostics today announced an expanded scope contract with the US Defense Advanced Research Projects Agency (DARPA), where DARPA will apply additional resources and funds to accelerate progress...

Learn More

Amgen and Adaptive Biotechnologies Announce Strategic Partnership to Develop a Therapeutic to Prevent or Treat COVID-19

By: Colorado BioScience Association   Date: 04/02/2020

Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and deve...

Learn More

Aktivax, Inc. has been awarded a $16 million contract from the Biomedical Advanced Research and Development Authority (BARDA)

By: Colorado BioScience Association   Date: 04/01/2020

Shortly after receiving a $24.5 million project from the Department of Defense (DOD) to develop a scopolamine auto-injector, Aktivax, Inc. has been awarded a $16 million contract from the Biomedical A...

Learn More

Flagship Biosciences Hires New Vice President of Clinical Diagnostics

By: Colorado BioScience Association   Date: 03/31/2020

Flagship Biosciences, providers of expert tissue data insights, today announced that Geoff Metcalf, MBA, PMP, will join its executive team as Vice President Clinical Diagnostics. Geoff brings 25 years...

Learn More